Project Grant HT94252410921
Award Date
11/1/24
Completion Date
10/31/27
Dollars Obligated
$603K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Omaha, NE 68198, USA
Similar Awards
This $602,550 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) supports adoptive cellular therapy research for pancreatic cancer. The awardee, the University of Nebraska Medical Center (UNMC), will conduct innovative biomedical research to develop novel therapeutic approaches, perform clinical trials, and provide technical expertise in this critical medical field. As a prominent academic research...
The Department of the Army Medical Command, through the Military Medical Research and Development federal grant program (CFDA 12.420), awarded a $556,200.00 project grant to the University of Nebraska Medical Center (UNMC) for "ADOPTIVE CELLULAR THERAPY FOR PANCREATIC CANCER". The award, with a period of performance from October 1, 2024 to September 30, 2027, will fund advanced biomedical research to develop innovative treatments for pancreatic cancer. UNMC, a prominent academic...
The Defense Health Agency awarded a $579,375 Project Grant to the University of Nebraska Medical Center through the Military Medical Research and Development program (CFDA 12.420) to support research targeting APE1 interaction with DNA G-quadruplex to prevent metastasis in triple-negative breast cancer. The three-year award beginning December 30, 2022 will fund research by the University of Nebraska Medical Center to investigate medical solutions for metastatic breast cancer through innovative...
This federal Project Grant award of $183,220.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) is supporting research at the University of Nebraska Medical Center (UNMC) to target the CCL17/CCR4 axis to eradicate lung cancer brain metastasis. The award, which began on February 1, 2025 and will be completed by January 31, 2026, aims to advance biomedical research that transforms healthcare for military service members, veterans, and the broader...
The Defense Health Agency awarded a $579,375 Project Grant to the University of Nebraska Medical Center to support research targeting APE1 interaction with DNA G-quadruplex to prevent metastasis in triple-negative breast cancer. The grant is funded through the Military Medical Research and Development program (CFDA 12.420) and aims to transform health care for service members and the public through innovative biomedical research investigating medical solutions for the battlefield. The University...
The University of Nebraska Medical Center (UNMC) was awarded a $1,544,999.00 Project Grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on a "NOVEL ER STRESS MITIGATION PATHWAY IN ERBB2-DRIVEN ONCOGENESIS". The grant, which has a performance period from May 1, 2024 to April 30, 2027, will support UNMC's investigation of an innovative pathway for mitigating endoplasmic reticulum (ER) stress in ErbB2-driven...
The Department of the Army Medical Command awarded a $1.5 million Project Grant to the University of Nebraska Medical Center to support research targeting nuclear importins in pancreatic ductal adenocarcinoma (PDAC) under the Military Medical Research and Development program. The three-year award beginning July 1, 2022 will fund research exploring medical solutions for pancreatic cancer through investigation of nuclear transport proteins that mediate entry of molecules into the cell nucleus....
The University of Nebraska Medical Center (UNMC) was awarded a $927,000 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "TARGETING FGFR4 SIGNALING TO OVERCOME CHEMORESISTANCE IN OVARIAN CANCER". The grant has an award date of July 1, 2024 and an ultimate completion date of June 30, 2028. UNMC, a leading institution in health sciences education, innovative research, and patient care, will...
The federal Project Grant award of $848,335.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development (CFDA 12.420) program supports a research initiative titled "NOVEL THERAPEUTIC APPROACH TO PREVENT UVEAL MELANOMA PROGRESSION" at the University of Nebraska Medical Center (UNMC). This 3-year award, running from August 1, 2025 to July 31, 2028, will fund advanced biomedical research aimed at transforming healthcare for military service members,...
The Defense Health Agency awarded a $828,591 Project Grant under CFDA 12.420, the Military Medical Research and Development program, to Duke University. The grant supports research titled "Targeting the Tumor Microenvironment to Enhance Immunotherapy for SCLC", with a performance period from May 1, 2025 to April 30, 2027. This research aims to transform healthcare for military service members, veterans, and the public by advancing innovative biomedical investigations focused on...